Collectively, mitochondrial dysfunction plays a pivotal role in the development of DCM, while modulating PPARα activity via PGC1 is a promising approach to attenuate mitochondrial dysfunction. The gene discussed is PPARGC1A; the disease is familial dilated cardiomyopathy.